Efficacy, Tolerability and Safety of NVA237 in Patients With Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Novartis Pharmaceuticals
Related studies linked through entity extraction aliases.
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
- Status
- COMPLETED
- Phase
- PHASE1
BKM120 in Cancers With PIK3CA Activating Mutations
- Status
- WITHDRAWN
- Phase
- PHASE2
Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod
- Status
- TERMINATED
- Phase
- PHASE3
Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Efficacy of Fingolimod in de Novo Patients Versus Fingolimod in Patients Previously Treated With a First Line Disease Modifying Therapy
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Vildagliptin as add-on Therapy to Metformin in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Safety and Tolerability of Fingolimod in Patients With Relapsing-remitting Multiple Sclerosis
- Status
- COMPLETED
- Phase
- PHASE3
Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
INC424 for Patients With Primary Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis.
- Status
- COMPLETED
- Phase
- PHASE3
Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
- Status
- COMPLETED
- Phase
- PHASE2
Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
- Status
- COMPLETED
- Phase
- PHASE2
Telemonitoring Study - for Chronic Myeloid Leukemia (CML)
- Status
- TERMINATED
- Phase
- NA
Effect of Physical ACtivity in Fingolimod Treated patiEnts (PACE) With Relapsing-remitting Multiple Sclerosis
- Status
- TERMINATED
- Phase
- PHASE4
The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Dose-escalation, and Safety Study of LDE225 and Gemcitabine in Locally Advanced or Metastatic Pancreatic Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients
- Status
- COMPLETED
- Phase
- PHASE1
Rivastigmine in the Management of Delirium
- Status
- COMPLETED
- Phase
- PHASE3